Literature DB >> 6995485

Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.

G W Hunninghake, J E Gadek, H M Fales, R G Crystal.   

Abstract

The presence of neutrophils within the lung is a characteristic feature of a variety of lung diseases. To evaluate the potential role of alveolar macrophages in modulating the migration of neutrophils to the lung, normal human alveolar macrophages obtained from volunteers by bronchopulmonary lavage, were exposed for various periods of time in vitro to heat-killed microorganisms, and noninfectious particulates, immune complexes, and the macrophage supernates were evaluated for chemotactic activity. The microorganisms, noninfectious particulates, and immune complexes were chosen as stimuli for alveolar macrophages because these stimuli are representative of a spectrum of pathogenic agents that cause neutrophil accumulation in the lower respiratory tract. After incubation with each of these stimuli, alveolar macrophages released low molecular weight (400-600) chemotactic factor(s) (alveolar macrophage-derived chemotactic factor[s] [AMCF]) with relatively more activity for neutrophils than monocytes or eosinophils. Checker-board analysis of the AMCF revealed that the factor was primarily chemotactic and not chemokinetic for neutrophils. The selectivity for neutrophils vs. monocytes could not be explained by a selective deactivation of monocytes, because the AMCF was more potent in deactivating neutrophils than monocytes. Partial characterization of AMCF demonstrated it was heterogeneous with the following features: (a) stable to heating at 56 and 100 degrees C for 30 min; (b) stable over a pH range of 1.0 to 12.0 for 60 min; (c) stable after exposure to trypsin, papain, chymotrypsin, collagenase, and elastase; (d) partially inhibited by serum chemotactic factor inhibitor(s); (e) two major isoelectric points (pI 7.6 and 5.2); and (f) partially extractable into ethyl acetate, ether, and hexane. Although AMCF was, at least, partially lipid in nature, it did not appear to be similar to previously described lipid chemotactic factors (e.g., hydroxy-derivatives of 5,8,10,14-eicosatetraenoic acid); analysis by gas chromatography-mass spectrophotometry of AMCF extracted into ethyl acetate did not reveal the presence of 5,8,10,14-eicosatetraenoic acid. The macrophage supernates containing the AMCF also stimulated normal human neutrophils to release lysozyme and lactoferrin but not lactate dehydrogenase. These studies suggest that a wide variety of potentially pathogenic stimuli induce normal alveolar macrophages to generate a low molecular weight chemotactic factor(s) that preferentially attracts neutrophils. Because alveolar macrophages are normal residents of alveoli, it is likely that by releasing this factor(s) macrophages play a significant role in amplifying the inflammatory processes seen in many acute and chronic lung diseases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995485      PMCID: PMC371675          DOI: 10.1172/JCI109878

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.

Authors:  J I Gallin; R A Clark; M M Frank
Journal:  Clin Immunol Immunopathol       Date:  1975-01

2.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  H Y Reynolds; J D Fulmer; J A Kazmierowski; W C Roberts; M M Frank; R G Crystal
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

4.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

5.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

6.  C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.

Authors:  P A Ward; J H Hill
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

7.  Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.

Authors:  E J Goetzl; J M Woods; R R Gorman
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.

Authors:  A P Kaplan; E J Goetzl; K F Austen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

9.  Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung.

Authors:  G W Hunninghake; J E Gadek; R C Young; O Kawanami; V J Ferrans; R G Crystal
Journal:  N Engl J Med       Date:  1980-03-13       Impact factor: 91.245

10.  Chemotactic activity in dialyzable transfer factor.

Authors:  J I Gallin; C H Kirkpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

View more
  48 in total

Review 1.  The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema.

Authors:  J E Gadek; E R Pacht
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.

Authors:  T R Martin; G Raugi; T L Merritt; W R Henderson
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

Review 3.  [Imaging of emphysema].

Authors:  C Grosse; A Bankier
Journal:  Radiologe       Date:  2007-05       Impact factor: 0.635

Review 4.  Lung collagen: more than scaffolding.

Authors:  G J Laurent
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

5.  T cell-dependent chronic neutrophilia during mycobacterial infections.

Authors:  R Appelberg; M T Silva
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

6.  Endotoxin-stimulated human macrophages produce a factor that induces polymorphonuclear leucocyte infiltration and is distinct from interleukin-1, tumour necrosis factor alpha and chemotactic factors.

Authors:  P Megyeri; J Sadowska; T B Issekutz; A C Issekutz
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

7.  Characterization of a preclinical model of chronic ischemic wound.

Authors:  Sashwati Roy; Sabyasachi Biswas; Savita Khanna; Gayle Gordillo; Valerie Bergdall; Jeanne Green; Clay B Marsh; Lisa J Gould; Chandan K Sen
Journal:  Physiol Genomics       Date:  2009-03-17       Impact factor: 3.107

8.  Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  G W Hunninghake; J E Gadek; T J Lawley; R G Crystal
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

9.  Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization.

Authors:  P B Bitterman; S I Rennard; G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

10.  Role of alveolar macrophages in asbestosis: modulation of neutrophil migration to the lung after acute asbestos exposure.

Authors:  C I Schoenberger; G W Hunninghake; O Kawanami; V J Ferrans; R G Crystal
Journal:  Thorax       Date:  1982-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.